Person

Barry J. Regan

Formerly EVP Operations, Dexcom

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$2.9M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • DXCM
    Dexcom
    EVP Operations
    Nov 2020 – last filing Dec 2023

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 8, 2023DXCMSale2,019$95.22$192K
Jul 10, 2023DXCMSale1,989$128.05$255K
Apr 20, 2023DXCMSale2,214$124.50$276K
Mar 13, 2023DXCMSale2,010$106.27$214K
Jan 30, 2023DXCMSale2,213$106.12$235K
Mar 29, 2022DXCMSale1,106$500.00$553K
Dec 13, 2021DXCMSale1,214$563.93$685K
Nov 22, 2021DXCMSale837$638.65$535K

SEC reporting-owner ID (CIK) 1746313 · all filings on EDGAR